LHC-CIDI-5 in Hong Kong
Recruiting
Observational Study
Major Depressive Episode (MDE)
Major Depressive Disorder (MDD)
Persistent Depressive Disorder (PDD)
Suicidal Ideation
Suicidal Plan
Suicidal Attempt
Suicidal Gesture
Nonsuicidal Self-Injury
Manic Episode
Hypomanic
Bipolar I Disorder
Bipolar Sub Disorder
Bipolar II Disorder
Generalized Anxiety Disorder (GAD)
Intermittent Explosive Disorder (IED)
Panic Attack
Panic Disorder
Obsessive-Compulsive Disorder (OCD)
Posttraumatic Stress Disorder (PTSD)
PCL-SC PTSD
PCL-5 PTSD
Alcohol Use Disorder (AUD)
Substance Use Disorder (SUD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 25 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,500 (estimated)
- Sponsor
- The University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The World Health Organization Composite International Diagnostic Interview-5th (CIDI-5) is a standardized diagnostic tool used to assess the prevalence of mental and substance use disorders over varying time frames (30 days, 12 months, and lifetime) based on the diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) and International Classific…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All household members aged 25 years old and over are randomly sampled from the Census and Statistics Department List of Quarters
* Live in the address sampled from the Census and Statistics Department List of Quarters
* Reside in Hong Kong for at least six months in the past y…
Contacts